From Clinic to Laboratory: Modernizing TB Infection Testing with T-SPOT.TB

Tuesday, July 28
7:00 – 8:30 a.m.
Hilton Anaheim, California A
Presented by Euroimmun US

Overview

Tuberculosis (TB) remains a significant global health challenge, with accurate detection of TB infection critical for prevention and control. This workshop examines the clinical utility and workflow advantages of T-SPOT.TB, an interferon-gamma release assay (IGRA) for TB infection, across diverse testing scenarios.

First, Dr. Juzar Ali will present a clinical overview of latent TB and review data supporting T-SPOT.TB, including the value of the borderline result category and assay performance in varied patient populations. A laboratory professional will then share real-world experience running T-SPOT.TB on the AP2400 automated platform, highlighting operational benefits and the impact of automation on TB testing.

Outcome

1. Describe the clinical role of T-SPOT.TB in detecting TB infection, including the diagnostic significance of the borderline result category and assay performance across varied patient populations.
2. Evaluate clinical evidence supporting the use of T-SPOT.TB as an interferon-gamma release assay (IGRA) for TB infection screening and diagnosis in routine practice.
3. Identify the operational benefits of automating T-SPOT.TB testing, including improvements in workflow efficiency, throughput, and consistency in the clinical laboratory.

Moderator

Jackie Weiss
Scientific Affairs Liaison
Euroimmun US

Speaker

Juzar Ali, MD, FRCP(C), FCCP
LSU Alumni Klein Professor (Emeritus/Gratis) of Medicine, Section of Pulmonary / Critical Care
LSU Health Sciences Center